Navigation Links
Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011

ST. LOUIS, Aug. 25, 2011 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today announced that executive management will present at the Stifel Nicolaus Healthcare Conference to be held September 7-9, 2011 in Boston, MA.  Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis, is scheduled to present an overview of the Company on Wednesday, September 7, 2011 at 4:25 p.m. ET.

A live webcast and subsequent archived replay of the presentation will be accessible at, in the "Investor Relations" section under "Events & Presentations."  

About Stereotaxis   

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure.

Stereotaxis' Odyssey™ portfolio of products provides an innovative enterprise solution for integrating, recording and networking interventional lab information within hospitals and around the world. Odyssey™ Vision integrates data for magnetic and standard interventional labs, enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. Odyssey™ Enterprise Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed.  Odyssey™ then enables hospitals to efficiently share live and recorded clinical data anywhere around the world to maximize referrals and promote collaboration.

The core components of the Stereotaxis systems have received regulatory clearance in the U.S., Europe, Canada and elsewhere. For more information, please visit and

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase our systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that the Company will recognize revenue related to its purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of the Company's control. In addition, these orders and commitments may be revised, modified, delayed or canceled, either by their express terms, as a result of negotiations, or by overall project changes or delays.

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011
2. Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™
3. Stereotaxis to Report Second Quarter 2011 Financial Results and Conduct Conference Call on August 8, 2011
4. Stereotaxis and Biosense Webster Announce New Strategic Collaboration
5. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
6. Stereotaxis Reports First Quarter 2011 Financial Results
7. Stereotaxis Introduces New Electrophysiology Platform: Epoch™
8. Stereotaxis to Present at Upcoming Investor Conferences
9. Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook
10. Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
11. Stereotaxis to Report Fourth Quarter and Full Year 2010 Financial Results and Conduct Conference Call on February 28, 2011
Post Your Comments:
(Date:11/30/2015)... Belgium , Nov. 30, 2015   ... focused on developing blood-based diagnostic tests for a broad range ... will present at the LD Micro Conference, which will be ... CA. Attending from VolitionRx will be David ... Powell , Vice President of Investor Relations. ® ...
(Date:11/30/2015)... IRVINE, Calif. and REHOVOT, Israel ... privately held specialty pharmaceutical company focused on acquiring and ... disorders, today announced the appointment of Keith A. ... directors. Gregory J. Flesher , chief executive ... experience in building successful organizations.  As chairman, he will ...
(Date:11/29/2015)... 2015   Royal Philips  (NYSE: PHG, AEX: PHIA) ... the 2015 Radiological Society of North America Annual Meeting ... in Chicago . Visitors to the ... broad portfolio of integrated Diagnostic Imaging, Clinical Informatics, Image ... performance, improve workflow and create a superior patient experience. ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... ... It’s inevitable that everyone will experience death in his or her lifetime. ... lives among us. It is your perspective, however, that determines how you view death ... T Sky understands that she may see death more frequently than most. As she ...
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today that ... Their Ecosystem empowers dentists to make complex business decisions by providing the tools and ... a free fee survey with 10 procedures customized by zip code. , The ...
(Date:11/30/2015)... ... 30, 2015 , ... Insightra Medical, Inc. and Novus Scientific ... for soft tissue repair in the US via Insightra’s national direct sales channel. ... intended to support and reinforce soft tissue for 6-9 months before absorbing completely ...
(Date:11/30/2015)... Columbia, Maryland (PRWEB) , ... November 30, 2015 ... ... human interactions could be of critical importance to the medical schools of the ... SIMmersion exhibited its healthcare suite at the 2015 ChangeMedEd conference in Chicago, organized ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... a leading provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced ... Microsoft Partner Program with competencies in the Application Development, demonstrating a “best-in-class” ...
Breaking Medicine News(10 mins):